US forecaster sees higher chance of La Nina conditions this summer By Reuters
[ad_1] (Reuters) – A U.S. government weather forecaster projects El Nino conditions will likely end by spring this year but saw a 62% chance that...
Rev group sees $127.6 million in stock sold by American Industrial Partners By Investing.com
[ad_1] © Reuters. In a recent move that has caught the attention of the investment community, American Industrial Partners, through its various entities, has sold...
Aramco chief sees healthy Chinese demand, looking at more investments By Reuters
[ad_1] © Reuters. File photo: President and CEO of Aramco Amin Nasser speaks at China Development Forum 2023, in Beijing, China, on March 26, 2023....
Earnings call: Smith & Wesson sees growth in Q3, aims for debt-free year-end By Investing.com
[ad_1] © Reuters. Smith & Wesson Brands, Inc. (SWBI) has reported a notable increase in net sales and market share during the third quarter of...
Amplifon sees U.S. demand lifting revenue growth in 2024 By Reuters
[ad_1] © Reuters. (Reuters) – Italian hearing aid maker Amplifon expects high-single-digit growth in 2024 revenues at constant exchange rates, as its market expands in...
UBS bullish on Pentair stock, sees growth potential By Investing.com
[ad_1] © Reuters. On Thursday, UBS maintained its Buy rating on Pentair (NYSE:) stock with a steadfast price target of $83.00. The firm’s confidence in...
Guggenheim sees Dollar Tree ‘among best-positioned retailers’, lifts stock PT By Investing.com
[ad_1] © Reuters. Tuesday, Guggenheim maintained a positive stance on Dollar Tree (NASDAQ:), raising its price target to $170.00 from the previous $155.00 while keeping...
Earnings call: Strategic Education sees robust Q4 growth, plans investment By Investing.com
[ad_1] © Reuters. Strategic Education Inc. (NASDAQ:) has reported a notable increase in its fourth-quarter revenue and a significant leap in operating income, according to...
JPMorgan bullish on Kyverna Therapeutics stock, sees ‘significant’ potential By Investing.com
[ad_1] © Reuters. Monday – Kyverna Therapeutics Inc (NASDAQ:KYTX) has received a new Overweight rating from JPMorgan, with the investment firm setting a price target...
Earnings call: InterRent REIT sees growth in Q4 with strategic capital moves By Investing.com
[ad_1] © Reuters. InterRent REIT (IIP-UN.TO) has reported a strong performance in the fourth quarter of 2023, highlighting increased occupancy rates, rental growth, and positive...